Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLGO
2001
Pelagos Insurance Capital
PLGO
$2.04B
| $2.16M | ﹤0.01% |
118,985
+66,885
| +128% | +$1.24M |
|
2002
Shoals Technologies Group
SHLS
$1.42B
| $2.16M | ﹤0.01% |
+389,700
| New | +$1.98M |
|
2003
Amprius Technologies
AMPX
$1.83B
| $2.14M | ﹤0.01% |
765,100
+752,000
| +5,740% | +$1.31M |
|
|
PMT
2004
PennyMac Mortgage Investment
PMT
$824M
| $2.14M | ﹤0.01% |
+169,900
| New | +$2.3M |
|
2005
electroCore
ECOR
$89.9M
| $2.14M | ﹤0.01% |
131,786
+58,800
| +81% | +$679K |
|
2006
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
| $2.13M | ﹤0.01% |
45,000
-375,200
| -89% | -$17.9M |
|
2007
Skyward Specialty Insurance
SKWD
$2.42B
| $2.13M | ﹤0.01% |
42,100
+4,400
| +12% | +$214K |
|
|
BKV
2008
BKV Corp
BKV
$2.93B
| $2.12M | ﹤0.01% |
+89,300
| New | +$1.81M |
|
|
PHLT
2009
DELISTED
Performant Healthcare Inc
PHLT
| $2.12M | ﹤0.01% |
702,863
-30,900
| -4% | -$106K |
|
2010
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$19.1B
| $2.12M | ﹤0.01% |
38,700
+34,400
| +800% | +$1.94M |
|
|
GRP.U
2011
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $2.12M | ﹤0.01% |
43,600
-800
| -2% | -$42.7K |
|
2012
BuzzFeed
BZFD
$92.5M
| $2.12M | ﹤0.01% |
792,318
+619,892
| +360% | +$1.95M |
|
2013
National Health Investors
NHI
$3.58B
| $2.11M | ﹤0.01% |
30,500
-51,700
| -63% | -$3.93M |
|
2014
Aclaris Therapeutics
ACRS
$851M
| $2.11M | ﹤0.01% |
850,519
-520,181
| -38% | -$1.29M |
|
|
IVAC
2015
DELISTED
Intevac Inc
IVAC
| $2.11M | ﹤0.01% |
619,977
+44,804
| +8% | +$142K |
|
2016
United Fire Group
UFCS
$1.4B
| $2.11M | ﹤0.01% |
74,083
-22,400
| -23% | -$565K |
|
2017
Protalix BioTherapeutics
PLX
$179M
| $2.1M | ﹤0.01% |
1,118,000
+162,100
| +17% | +$229K |
|
|
PYCR
2018
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $2.1M | ﹤0.01% |
+113,100
| New | +$1.89M |
|
2019
Regenxbio
RGNX
$711M
| $2.1M | ﹤0.01% |
+271,300
| New | +$2.55M |
|
2020
Cardiff Oncology
CRDF
$74.9M
| $2.1M | ﹤0.01% |
483,090
-119,294
| -20% | -$373K |
|
2021
F&G Annuities & Life
FG
$3.59B
| $2.09M | ﹤0.01% |
50,500
+2,100
| +4% | +$92.5K |
|
2022
Corvus Pharmaceuticals
CRVS
$1.25B
| $2.09M | ﹤0.01% |
390,688
+4,100
| +1% | +$30.6K |
|
2023
BayCom
BCML
$339M
| $2.09M | ﹤0.01% |
77,844
+5,244
| +7% | +$138K |
|
2024
Ponce Financial Group
PDLB
$502M
| $2.09M | ﹤0.01% |
160,435
+2,700
| +2% | +$33.1K |
|
2025
California Water Service
CWT
$3.12B
| $2.08M | ﹤0.01% |
+45,992
| New | +$2.32M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.